Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Summary

A prospective, randomized, double-masked study that evaluated the ocular efficacy and safety of two doses of the EYP-1901 intravitreal (IVT) insert compared to sham.

Timeline

Start

2022-09-28

Primary completion

2024-02-12

Completion

2024-05-06

Drugs

Indications